Forbes -
22 Jul 2020 16:30

While Moderna was viewed as a front-runner in the race for a Covid-19 vaccine, competition is mounting. On Monday, Oxford University, which is developing a Covid-19 vaccine candidate along with AstraZeneca, published some positive data on phase 1/2 trials, indicating that the vaccine was...
Share this Article
Comment on this Article
Please to comment